Analysts Viewpoint Examining the Potential Price Growth of Werewolf Therapeutics Inc (HOWL) Werewolf Therapeutics Inc’s recent filing unveils that its Director RA CAPITAL MANAGEMENT, L.P. acquired Company’s shares for reported $0.28 million
Stock Earnings The Potential Rise in the Price of Werewolf Therapeutics Inc (HOWL) following insiders activity Werewolf Therapeutics Inc’s filing revealed that its Director RA CAPITAL MANAGEMENT, L.P. acquired Company’s shares for reported $0.28 million on